Search Clinical Trials
Home >  Clinical Trials & Research >  Search Clinical Trials
Print

Clinical Trials & Research

Search Clinical Trials

Clinical Trials

New Search
Title   A Randomized, Phase II Efficacy Assessment of Multiple MET Kinase Inhibitors (Cabozantinib NSC 761968, Crizotinib NSC 749005, Savolitinib NSC 785348, and Sunitinib NSC 736511) in Metastatic Papillary Renal Carcinoma (PAPMET)
Full Title   A Randomized, Phase II Efficacy Assessment of Multiple MET Kinase Inhibitors (Cabozantinib NSC 761968, Crizotinib NSC 749005, Savolitinib NSC 785348, and Sunitinib NSC 736511) in Metastatic Papillary Renal Carcinoma (PAPMET)
Disease/Condition   Medical and Hematologic Oncology
Description  

Click here for more information

Eligibility Criteria   Click here for eligibility requirements
Principal Investigator   Benjamin Gartrell
Contact Name   Francigna Rodriguez
Contact Email   frarodri@montefiore.org
vcaldero@montefiore.org
Protocol Number   IRB# 2017-7787
Inclusion/Notes   This information was obtained from ClinicalTrials.gov.
Status   Enrolling
Adult Clinical Trial   No
Pediatric Clinical Trial   No